BiotechTube
Home/Alligator Bioscience/Karin Nordbladh
KN

Karin Nordbladh

Board Member (Employee Representative)

Alligator Bioscience

Therapeutic Areas

Oncology

Alligator Bioscience Pipeline

DrugIndicationPhase
MitazalimabFirst-line metastatic pancreatic ductal adenocarcinoma (PDAC)Phase 2
Undisclosed Bispecific ProgramsOncology (unspecified)Discovery/Preclinical

Leadership Team at Alligator Bioscience

SB
Søren Bregenholt
Chief Executive Officer (CEO)
JG
Johan Giléus
Chief Financial Officer (CFO)
HO
Hans-Peter Ostler
Chairman of the Board
DG
Denise Goode
Board Member
ES
Eva Sjökvist Saers
Board Member
View full Alligator Bioscience profile